Arena Pharmaceuticals

News and Video Search Results

News coverage

Global Tetraspecific Antibodies Clinical Trials & Market Report 2024: Pioneering the Future of Cancer Treatment, Shift Towards Tetraspecific Antibodies Amidst Drug Resistance Challenges

GlobeNewswire 31 May 2024

Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Insight 2024"..

Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 30 May 2024
Global Sickle Cell Disease Treatment Market Report 2024: Robust Expansions Projected by 2031 with AstraZeneca., Eli Lilly and Co, Bristol-Myers Squibb Spearheading Growth
GlobeNewswire 29 May 2024
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
GlobeNewswire 28 May 2024
Biosimilars and Follow-on Biologics market is projected to grow at a CAGR of 14.8% by 2034: Visiongain
GlobeNewswire 23 May 2024

0 shares 1 views

You might like

Arena Pharmaceuticals media coverage

Anavex Life Sciences Announces Expansion of Leadership Team

GlobeNewswire 22 May 2024

Strengthening Operational Efficiency and Execution towards Sustainable Accessibility for Diverse Populations within Global..

UAE Cools Down with a $4.8 Billion Cold Chain: Market Poised for Growth by 2027: Ken Research
GlobeNewswire 20 May 2024
Worldwide Point-of-Care (POC) Diagnostic Tests Market Research 2024: Convergence of Digital Diagnostics and POC Technologies Reshapes Healthcare Delivery
GlobeNewswire 07 May 2024
Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli Lilly and Company, Merck Sharp & Dohme LLC, T
GlobeNewswire 02 May 2024
HDAC Inhibitor Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight
GlobeNewswire 24 Apr 2024

Advertisement

More coverage

Sermonix to Host KOL Fireside Chat on Advancements in the Metastatic Breast Cancer Treatment Landscape on April 22, 2024

GlobeNewswire 19 Apr 2024

COLUMBUS, Ohio, April 19, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company..

Eosinophilic Esophagitis Pipeline Research 2024
GlobeNewswire 19 Apr 2024
Global Vision Care Market Projected to Surpass US$ 102 Billion by 2030 as Demand for Advanced Eye Care Solutions Grows
GlobeNewswire 19 Apr 2024
Date Palms Reconceptualized: Is Tissue Culture the Game-changer in Date Palm Cultivation? FMI Debate on Evolution in Agricultural Arena!
GlobeNewswire 17 Apr 2024
Global Transdermal Patches Market Projected to Reach $8.5 Billion by 2030 with a CAGR of 5.1%
GlobeNewswire 04 Apr 2024